Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank14
3Y CAGR-41.4%
5Y CAGR-32.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-41.4%/yr
vs -4.9%/yr prior
5Y CAGR
-32.3%/yr
Recent deceleration
Acceleration
-36.4pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $64.72M | -49.8% |
| 2024 | $128.81M | -40.6% |
| 2023 | $216.74M | -32.6% |
| 2022 | $321.33M | -19.6% |
| 2021 | $399.43M | -12.3% |
| 2020 | $455.58M | -1.5% |
| 2019 | $462.49M | +17.5% |
| 2018 | $393.68M | +30.5% |
| 2017 | $301.68M | +11.8% |
| 2016 | $269.94M | - |